Cancer Res (2022) 82 (12_Supplement): 5443.

Cancer Res (2024) 84 (6_Supplement): 48. Introduction: Multiple Myeloma (MM) is the second most diagnosed hematologic malignancy and remains an incurable disease. KLN-1010 is a novel treatment for MM ...

2020 Meetings Abstracts: AACR Special Conference on Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies January 9–12, 2020; San Diego, CA ...

1The Second Clinical Medical School, Lanzhou University, Lanzhou, China. 2Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China. 3Gansu Tumor Immunology Basic Disciplines ...

1Department of Anatomy, University of California, San Francisco, San Francisco, California. 2Department of Cell, Developmental & Cancer Biology, Oregon Health and ...

Nathan Mantel; The Detection of Disease Clustering and a Generalized Regression Approach. Cancer Res 1 February 1967; 27 (2_Part_1): 209–220. While the distance measures between points represent ...

1Yonsei University, College of Medicine, Seoul, Republic of Korea.

Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.

1Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, ...

1Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan. Search for other works by this author on: 1Department of Clinical Pharmacology and ...

1Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China. 2State Key ...

The combination of anti-TROP2 ADCs with PD-(L)1 inhibitors represents a promising therapeutic strategy, merging targeted therapy with immunotherapy to improve treatment outcomes. Clinical trials are ...